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ABSTRACT (Maximum 200 Words)
A marked propensity for prostate cancer to arises in the peripheral prostate with aging. The Insulin-like Growth Factor-II (IGF2) gene is an auto-paracrine growth stimulator that is an important positive modulator of cancer development. IGF2 typically demonstrates monoallelic, or imprinted, expression in adult tissues and indeed this pattern is maintained in the periurethral zone, a region where cancer development is rare. In addition, IGF2 loss of imprinting (LOI), as well as increased IGF2 expression, are common attributes of prostate cancer. It is our hypothesis to be tested that an agedependent loss of IGF2 imprinting, resulting from age-dependent changes in DNA methylation, occurs specifically in the peripheral zone of the prostate and contributes to the increased risk for cancer development. To examine temporally when this loss of IGF2 imprinting occurs and the mechanisms underlying it we propose 3 Specific Aims: (1) To determine if IGF2 LOI in the peripheral prostate derives from stromal and/or epithelial cells; (2) To determine whether IGF2 LOI occurs as an age-dependent process in human prostate tissues that are uninvolved with cancer; and (3) To examine DNA methylation as a mechanism for any observed changes in the imprint status in prostate tissues. This proposal is significant and unique in testing whether regional epigenetic changes occur in histologically normal prostate tissues that are destined to become neoplastic. We expect to determine whether specific age-related, peripheral zone changes in methylation and imprinting occur in the general population and whether these changes are linked to prostate cancer development.
INTRODUCTION
Three important features of prostate cancer will be addressed in the present proposal that may provide a quantum leap in t l/egional Imprinting our understanding of the risk factors and[ Insulin-like Growth Factor-II (1GF2) gene hyperplasia originates. This pattern is found in most adult tissues.
In the peripheral zone, where prostate cancer arises, expression is is a auto-paracrine growth stimulator that from both inherited alleles(4).
is an important positive modulator of ' cancer development. We will provide preliminary evidence that a loss of imprinting, or biallelic expression, of the 1GF2 gene is an age-related specific epigenetic alteration that occurs in the peripheral prostate ( Figure 1 ). 1GF2 typically demonstrates monoallelic, or imprinted, expression in adult tissues and indeed this pattern is maintained in the periurethral zone, a region where cancer development is rare. In addition, IGF2 loss of imprinting (LOI), as well as increased 1GF2 expression, are common attributes of prostate cancer. Since DNA methylation is the major determinant of gene imprinting, we would anticipate that a loss of IGF2 imprinting in the prostate will be associated with specific changes in the 1GF2/H19 promoter regions. It is our hypothesis to be tested that an age-dependent loss of IGF2 imprinting, resulting from age-dependent changes in DNA methylation, occurs specifically in the peripheral zone of the prostate and contributes to the increased risk for cancer development. To examine temporally when this loss oflGF2 imprinting occurs and the mechanisms underlying it we propose 3 Specific Aims: (1) To determine iflGF2 LOI in the peripheral prostate derives from stromal and/or epithelial cells; (2) To determine whether 1GF2 LOI occurs as an age-dependent process in human prostate tissues that are uninvolved with cancer; and (3) To examine DNA methylation as a mechanism for any observed changes in the imprint status in prostate tissues. We propose to confirm our preliminary observations through a comprehensive analysis of IGF2 LOI and DNA methylation analysis in aging prostate tissues associated with and without cancer. These studies will utilize a unique tissue bank containing normal prostate tissues of various ages. Several innovative techniques including laser capture microdissection and quantitative allelespecific imprinting assays will also be employed.
BODY
Task 1: To determine whether a LOI in IGF2 arises from prostate epithelial cells, stromal cells or both in normal human prostate tissues. 1. Acquisition and histologic analysis of prostate specimens, DNA production (Months 1-3) : We have histologically examined tissues to exclude concomitant cancer, made DNA and screened over 70 samples for the Apal polymorphism. Twenty-five have been found to contain the Apal polymorphism. DNA has been extracted from these tissues. 2. Laser capture microdissection of stromal and epithelial cells from normal peripheral zone prostate tissues and RNA isolation (Months 1-12): We have utilized laser capture to separate Jarrard, the stroma from the epithelium in 5 tissues from the peripheral prostate of samples from men in their 60's.
Imprinting analyses using RJT-PCR/restriction enzyme digestion and development of quantitative allele-specific PCR assay (Months 2-14).:
We have found that in all 3 samples of normal peripheral prostate analyzed to date, both the epithelium and stroma demonstrate biallelic expression (Figure 2 ). This is remarkable since adult tissues maintain a tight monoalleleic regulation of this gene. The epithelialspecific change suggests a regional epigenetic cell-specific alteration may predispose these cells to the formation of cancer. This would support our hypothesis. Furthermore, this validates the epithelium as the cell of origin for prostate cancer. The stromal expression may function through an inductive (paracrine) effect on the epithelium. Stromal-specific alterations are important in the Figure 2 . Relaxation of IGF2 imprinting in both 0141 01sf 0211 the epithelium and stroma from normal peripheral F, s r 5 S C,,.?,,, prostate tissues. Microdissected stroma and Sepithelium was subjected to the Apal imprinting assay and gel analyzed. Biallelic expression is seen in both the epithelium and stroma from all three samples tested.
induction of epithelial cancers and could possibly represent an important clonal change.
We have also developed a new assay based on SNuPE (single nucleotide primer extension) for the IGF2 gene that is sensitive and applicable to multiple polymorphisms in the IGF2 gene. Briefly, RNA was extracted from frozen prostate tissue and used to generate cDNA by using Omniscript reverse transcriptase from Qiagen. The region that covers the SNP site on IGF2 exon 9 was amplified by PCR. ExoSAP-IT® (USB) was used to remove excess dNTPs and primers in the PCR reaction. The FluPE reaction contains 10 nM of FAM labeled primer (5'-CCAATGTTTTCATGGTCTGAGCC), 0.75 U of HotStarTaq Polymerase (Qiagen), 200 IiM of each specific dNTP/ddNTP, up to 500 ng of ExoSAP treated PCR product and 5 mM of magnesium in a 20 lil volume. FLuPE is performed at 95'C 15 min, 25 cycles of 95°C 30 sec and 54°C 40 sec. The reaction mix together with GeneScan TM120 LIZ® size standard (ABI) was loaded on ABI PRISM® 3100 Genetic Analyzer, which is a fluorescence-based DNA analysis system using the technology ofca illaryelectrophoresis. GeneScan fragment analysis software was used to Jarrard, Because of RNA degradation, we had to take alternate measures to increase the number of samples. We screened a population of samples for additional polymorphisms in exon 9 of the IGF2 gene. We have found two additional polymorphisms including a C/T (266, frequency 10%) and C/G (1926, frequency 30%). These sites do not contain cutting sites for restriction enzymes, thus we have had to develop a new assay for assessing imprinting. Using florescent single-nucleotide primer extension (FLuPE) we are able to specifically and sensitively detect single nucleotide base changes to detect imprinting changes in tissues (above). This assay is reproducible with a standard error of the mean(SEM) of 1-2% ( Table 1 ). In addition, it is sensitive and able to detect 2-3% changes in allele concentration on mixing experiments (Figure 3) . It has taken 12 months (due to IRB issues and labor constraints at Pittsburgh), but we have obtained 24 samples from the University of Pittsburgh tissue bank from normal peripheral prostate tissue (12 older than 50, 12 younger than 40). This database has been Mixing Allele Expression with FluPE 
3500
The assay was performed as described
The assay is quantitative at
bias is seen at a 5/5 concentration for the 'allele 1'. . We have completed a final analysis from our tissue bank from men without prostate cancer. This consists of 6 samples, to date, all men over age 50. Degradation of RNA was found to have occurred in other samples from younger men due to a freezer problem. We find that a relaxation of imprinting occurs in all of these samples, and that it ranges from 25 to 90% (Table 1) . In older patients, the loss of imprinting was almost complete in some samples. Histopathology did not show any cancer or inflammation differences between the analyzed specimens. Ongoing analyses of samples from Pittsburgh will provide data addressing this aim and a definitive conclusion regarding the loss of imprinting in aging. We expect to have this data completed in the next 2 months. DAMD 17-02-1-0163 To examine the role of methylation in IGF2 imprinting regulation and identify candidate regions to test in the human samples, we performed and have reported on several experiments (JBC, 2004) . We find that DNA methylation inhibition using 2-deoxy 5'azacytidine leads to an accelerated loss of IGF2 imprinting in HPEC cells. These changes include both a global 7 Jarrard, hypomethylation as well as regional hypermethylation of selected CpG islands ( Figure 5 ). replications. RI and R2 were the gates utilized for cell sorting. B, biallelic IGF2 expression develops in the high (High) fluorescent t , Ml tv fraction (RI) treated with D5-AzaC, in contrast to monoallelic expression from all other fractions. The cells in this high fluorescent fraction contain the senescent phenotype. C, CTCF is down-regulated in treated cells. Gene expression changes using QPCR are shown in sorted cell fractions. A high fluorescent cell fraction from treated cells (RI) is comnared with untreated cells.
We have found a consistent increase in DNA methylation in a differentially methylated region in the human, intergenic between H19 and IGF2, that appears to harbor a methylation imprinting mark for the IGF2 gene. Deletion or hypermethylation of this CpG island has been demonstrated in mouse models to lead to biallelic IGF2 expression(2). (Figure 6 ). An investigation of methylation at this locus is being assessed in the human prostate tissues recently obtained from Pittsburgh We have discovered that other epigenetic alterations may play an important role in the loss of imprinting in senescence (JBC, 2004) . CTCF is an insulator protein that binds in the IGF2/H19 intergenic region. Binding occurs on the nonexpressed allele and is hypothesized to prevent enhancer binding to the IGF2 promoter region. We have found that CTCF expression decreases over 10-fold in senescing prostate epithelial cells. Furthermore, knockdown of CTCF The imprinted insulin-like growth factor-2 (IGF2) development (1) . The insulin-like growth factor-2 gene (IGF2), gene is an auto/paracrine growth factor expressed only an auto-paracrine growth factor located at the 11p15 chromofrom the paternal allele in adult tissues. In tissues sus-somal locus, is imprinted and exhibits monoallelic expression ceptible to aging-related cancers, including the pros-from the paternal allele in most adult tissues. However, a tate, a relaxation of IGF2 imprinting is found, suggestrelaxation of the IGF2 imprint has been found in aging-associing a permissive role for epigenetic alterations in cancer ated human cancers, including cancer of the colon and prostate development. To determine whether IGF2 imprinting is (2, 3). Notably, re-expression of the silenced IGF2 allele was altered in cellular aging and senescence, human pros-also found in adjacent histologically normal tissues in these tate epithelial and urothelial cells were passaged seri-studies, suggesting that an alteration in imprinting had ocally in culture to senescence. Allelic analyses using an curred prior to the development of these cancers. The factors IGF2 polymorphism demonstrated a complete conver-that underlie this altered imprinting in vivo are unknown. sion of the IGF2 imprint status from monoallelic to bial-Given the age dependence of these types of cancers, progressive lelic, in which the development of senescence was assocellular replication and aging may play roles in modulating ciated with a 10-fold increase in IGF2 expression. As a mechanism, a 2-fold decrease in the binding of the en-genomic imprinting. hancer-blocking element CCCTC-binding factor (CTCF)
The process that limits the proliferative potential of normal within the intergenic IGF2-H19 region was found to un-human cells is termed senescence. Senescent cells demonstrate derlie this switch to biallelic IGF2 expression in senesa number of distinct characteristics, including an enlarged, cent cells. This decrease in CTCF binding was associflattened cytoplasm and nucleus, terminal growth arrest, and ated with reduced CTCF expression in senescent cells. specific gene expression changes (4). Senescence can be induced No de novo increases in methylation at the IGF2 CTCF by programmed or epigenetic changes resulting from repeated binding site were seen. The forced down-regulation of cell divisions and from cellular insults, including oxidative CTCF expression using small interfering RNA in imstress and DNA damage. Senescence may not be limited to an printed prostate cell lines resulted in an increase in in vitro phenomenon because cells expressing senescence-asso-IGF2 expression and a relaxation of imprinting. Our ciated 9-galactosidase activity, a marker for senescent cells, data suggest a novel mechanism for IGF2 imprinting accumulate with aging in human skin (5) and in a subset of regulation, that is, the reduction of CTCF expression in prostate epithelial cells from men with benign prostatic hyperthe control of IGF2 imprinting. We also demonstrate plasia (6). The examination of changes in global gene expresthat altered imprinting patterns contribute to changes sion in senescent human cells in culture reveals additional spein gene expression in aging cells.
cific genes that are altered in aging tissues, including PAI-1, t-PA, cathepsin B, activin A, tissue transglutaminase, several helicases, and members of the IGF1 axis (4, 7, 8). Several mechGenomic imprinting is an epigenetic modification that reanisms associated with aging in vivo can be found as cells unsults in the silencing of a specific allele, depending on its dergo senescence in vitro, including telomere shortening (9) and parental origin. Genomic imprinting plays a critical role in changes in DNA methylation, a postreplicative addition of modulating gene expression during embryogenesis and normal methyl groups within CpG dinucleotides (10). Thus, selected aspects of in vitro senescence are applicable to aging cells in vivo. * This work was supported in part by National Institutes of Health IGF2 is located within a cluster of imprinted genes on chroGrants K08CA76184 and R01CA97131, University ofWisconsin George mosome 7 in the mouse and on 11p15 in the human. The M. O'Brien Urology Research Center (1P50DK065303), Department of regulation of IGF2 and its closely linked and reciprocally imDefense Prostate Cancer Research Program (DAMD17-02-1-0163), the printed 3' neighbor, H19, has been studied intensely (11) both John Livesey endowment, and the American Federation for Aging Research. The costs of publication of this article were defrayed in part by because of its role in human disease and as a model for underthe payment of page charges. This article must therefore be hereby standing imprinting control mechanisms. During development, marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ¶ Supported through a National Institutes of Health training grant 1 The abbreviations used are: IGF, insulin-like growth factor; ICR, (T32 GM08688) to the Molecular and Cellular Pharmacology Training imprinting control region; CTCF, CCCTC-binding factor; HPEC, huProgram.
man prostate epithelial cell; QPCR, quantitative reverse transcriptase-** To whom correspondence should be addressed: University of Wis-PCR; MR, methylated region; CFSE, carboxyfluorescein diacetate succonsin Comprehensive Cancer Center, 600 Highland Ave., K6/530, cinimidyl ester; siRNA, small interfering RNA; GFP, green fluorescent Madison, WI 53792. Tel.: 608-265-2225; Fax: 608-265-8133. E-mail: protein; WT, Wilms' tumor; LOI, loss of imprinting; P, promoter; D5-jarrard@surgery.wisc.edu.
AzaC, 2'-deoxy-5-azacytidine.
IGF2 and H19 are expressed in a coordinate fashion that sug-cells were generated from human ureteral specimens. Cells were gests, in combination with their close linkage and reciprocal trypsinized and passaged at 1:2 or 1:3 dilutions when confluent and imprinting, common transcriptional elements. One model (the underwent typically 10-15 population doublings before becoming senescent. DNA and RNA were isolated from each passage. PC3 and insulator model) that has been developed in vitro (12, 13) and PPC-1 prostate cancer cell lines were obtained from the ATCC and in mouse models (14, 15) has focused on the differential meth-maintained in supplemented Dulbecco's modified Eagle's medium. ylation of an imprinting control region (ICR) located between Quantitative Reverse Transcriptase PCR-To compare gene expres-IGF2 and H19. ICRs provide gametic marks to establish the sion levels between proliferating and senescent cells, quantitative PCR parent-of-origin-dependent expression domains and are ac-was performed using an iCycler (Bio-Rad) and SYBR Green PCR master i ApidBoytm) 8SRAepeso a sda quired typically in the parental germ line and persist into r mix (Applied Biosystems). 18 S RNA expression was used as an internal control for normalizing samples. Primers were designed adulthood (16). When the H19 ICR is methylated on the paterfor p16, IGF2, and WT-1 using Primer Express (PerkinElmer Life nal allele, IGF2 is expressed. However, expression from the Sciences). 2 The IGF2 gene was spliced and transcribed by four promotmaternal allele is blocked when this ICR is unmethylated. The ers (P1, -2, -3, and -4) (28), and primers were designed to detect the boundaries of the mouse H19 ICR are not precise, yet deletion expression from each specific promoter. (or hypermethylation) of sequences between -3.8 and 2.0 kb on Imprinting Assays-To minimize DNA contamination, RQ1 DNase the maternal allele results in the biallelic expression of the (Promega) treatment of total RNA and intron-crossing primers were utilized. cDNA was synthesized using murine leukemia virus tranlinked and reciprocally imprinted IGF2 gene (17, 18). However, scriptase (Applied Biosystems) with random hexamers. Two pairs of biallelic H19 ICR methylation does not disrupt imprinting in primers were used to amplify an RNA-specific fragment containing the some cases of human Wilms' tumor (19) , suggesting that other IGF2 ApaI polymorphism on exon 9 (29). P1 (5'-GACACCCTCCAGTmechanisms may play a role in human tissues.
TCGTCTGT-3') and P2 (5'-CGGGGATGCATAAAGTATGAG-3') cross Recently, it has been found (12, 20) that the repression of the introns between exons 7, 8, and 9. The RNA-specific (1.3 kb) product maternal allele involves binding of a zinc finger CCCTC-bind-was separated from the DNA-specific (3.3 kb) fragment using a 1% agarose gel. The second pair of primers (P3 and P4) was used to perform ing factor, known as CTCF, which binds only unmethylated nested PCR (35 cycles), and 292-bp fragments were generated for re-DNA in this ICR. This binding blocks the access of downstream striction enzyme digestion with ApaI (New England Biolabs). P3 and P4 enhancer proteins to the IGF2 promoter region, which tran-primer sequences were 5'-CTTGGACTTTGAGTCAAATTGG-3' and 5'-scribes from multiple differentially expressed promoters P1-P4 GGTCGTGCCAATTACAfTTTCA-3', respectively. Cell line DNA with (21). Conversely, the hypermethylated paternal allele does not both alleles sensitive to enzyme digestion was utilized as a control for bind CTCF, and IGF2 is expressed from its promoters. There complete restriction digestion. Mixing controls using upper and lower alleles confirmed this approach to be quantitative. are clear structural differences when human and mouse seFor H19 amplification, cDNA was generated from informative samquences are compared. The mouse contains four CTCF binding ples, and primers (forward 5'-TGCACTACCTGACTCAGGAATC-3' and sites in the 1119 ICR in contrast to seven in the human; howreverse 5'-GTGATGTCGGTCGGAGCTTC-3') were used to amplify ever, only the sixth CTCF site demonstrates differential meth-across the H19 RsaI polymorphism (30). The intact product length was ylation (13, 22) . In addition, the human H19 ICR is not able to 544 bp, and the digested fragments were 406 and 138 bp if the polyfunction when introduced as a transgene in the mouse (23).
morphism was present. Analysis of CTCF Binding and Expression-Chromatin immunopreThis suggests that differences in the regulation of IGF2 imcipitation was performed as described previously (31), with minor modprinting may exist between species. It is also not clear what the ifications. Cross-linking was carried out by incubating cells (1 X 10') sequential relationship between CTCF binding and methyla-with a final concentration of 0.4% formaldehyde for 10 min at room tion is in the human. In mouse embryos, mutation of the ICR temperature. Cells were collected by centrifugation at 1200 rpm for 6 leads to decreased CTCF binding and de novo methylation, min, and nuclei were isolated. Chromatin was then precleared by incusuggesting a role for CTCF and its protein complex in mainbation with 50 Al of preimmune serum for 1 h followed by overnight incubation with 100 jkl of Immunopure protein A-agarose (Pierce). Samtaining a methylation-free domain (15).
ples were incubated with 30 jul bf anti-CTCF antibody (Upstate BioUsing a human model of cellular aging in which prostate technology). Immune complexes were collected by incubation with 30 gl epithelial and urothelial cultures were passaged sequentially, we of protein A-agarose for 2 h at 4 'C. Agarose beads were washed, and demonstrate that a complete loss of IGF2 imprinting develops immune complexes were eluted twice. Cross-links were reversed, and with the onset of senescence. Senescence is associated with a DNA was purified by extraction with phenol/chloroform followed by decrease in CTCF binding to the 1119 ICR, an event that results precipitation with ethanol. PCR was performed using real time quantitative PCR (QPCR) (Prism 7000 sequence detection system, ABI). The in increased maternal allelic IGF2 expression. The loss of CTCF product was measured by SYBR green fluorescence in 2 5 -t 1 reactions, binding is not associated with changes in methylation at the and the amount of the product was determined relative to a standard CTCF target site but is mediated by a decrease in CTCF protein curve generated from a titration of input chromatin. Primers for the expression. The present study details a novel model for examin-IGF2-H19 intergenic region were designed (5' and 3'): GAGGCTTCTCing imprinting mechanisms in pure populations of human cells CTTCGGTCTCA and GCCACTTCCGATTCCACAA. Western blot analduring a physiologic, programmed process. The down-regulation ysis was performed as described previously (32) using a polyclonal antibody for CTCF (Upstate Biotechnology, Lake Placid, NY) or antiof CTCF is a novel mechanism for imprinting regulation that P-actin (Sigma). may help to explain the lack of consistent correlation between Methylation Analyses-We examined four CpG islands in IGF2, of methylation of the H19 ICR and imprinting found in some huwhich three have been found to be methylated differentially in mice man tumor tissues (20, 24) . In addition, these data provide evi-and/or human tissues (33-37). The CpG islands that were tested were dence that a relaxation in imprinting has a permissive effect on located on IGF2 (GenBankTM accession no. AF125183) at exon 4 at 21170-21525 (MR1), exon 9 at 29080-29375 (MR2), between IGF2 and gene expression during cellular aging. Given that long term 1H19, 2 kb upstream of the H19 start site (H19 ICR/MR3), and at -906 chronic exposure to IGF2 appears to be important in the generto -275 in the H19 promoter (MR4). Genomic DNA isolated from both ation of tumors (25), the loss of imprinting and increased IGF2 proliferating and senescent HPEC/human urothelial cell cultures were expression may be important for the development of aging-retreated with sodium bisulfite (CpGenome DNA modification kit, Interlated cancers, especially in the prostate. gen) to convert unmethylated cytosines to uridines while retaining methylated cytosines as unchanged nucleotides. The regions were am-MATERIALS AND METHODS plified by primers MR1-F (5'-ACCCACTACAACTTCCCCAAC), MR1-R Tissue Culture-Human prostate epithelial culture (HPEC) or hu-(5'-TATTAGGAGTTTAGGTAG), MR2-F (5'-TTGGGTGGGTAGAGTAman urothelial cells were established on collagen-coated dishes in ATTAGG), MR2-R (5'-CTCAAATCACTAATCAATCAC), MR3-F (5'-Ham's F-12 supplemented medium containing 1% fetal bovine serum (26, 27). HPEC samples were obtained from human cystoprostatectomy specimens (ages 45-60) that did not contain prostate cancer. Urothelial 2 Primers designed forp16, IGF2, and WT-1 are available on request.
GTAGGGTTTTTGGTAGGTATAGAGT), and MR3-R (5'-CACTAAAAA-AACAATTATCAATTC), which are specific for the converted DNA. The A PCR products were then cloned into a pCR2. siRNA Transfection-HPECs, PPC-1, and PC3 cell lines were seeded to 50% confluence on 6-well plates 24 h prior to transfection. We used C
H19-Rsal
LipofectAMINE 2000 (Invitrogen) for HPECs and TransIT-TKO (Mirus Corp., Madison, WI) for cancer cell line transfection reagents. 50-100 pmol of CTCF SMARTpool (Dharmacon, Inc.) siRNAs were combined in a medium with the transfection reagents following the manufacturer's protocol. The mixture was then added by drops to the cells in complete 4 1 92 #93 Dulbecco's modified Eagle's medium and mixed by gentle rocking. Cells were retreated with siRNAs 12 h after the initial transfection. RNA and V N S I P S P Is S protein were harvested at 48 h. Experiments were performed in duplicate, with similar results.
*, CTCFLentivirus Infection-The open reading frame of human CTCF was cloned into the FUGW vector, which places the inserted DNA under the control of the ubiquitin promoter. A ubiquitin promoter was used in this experiment to express levels/cell of CTCF or green fluorescent protein (GFP) that were consistently lower than levels expressed by other more promiscuous promoters (e.g. cytomegalovirus). As a negative FIG. 1. Gene expression and imprinting changes in proliferatcontrol and to determine infection efficiency, a similar vector expressing ing and senescent epithelial cultures. A, gene expression level GFP was generated. Infectious virus was produced by transiently trans-changes are shown in senescent cultures. Gene expression levels were fecting lentivirus vector and packaging vectors into the 293T cell line, compared in proliferating and senescent HPEC and human urothelial as described elsewhere (38). Early senescent HPECs had 0.1 ml of cells using QPCR. p16 is a cyclin-dependent kinase inhibitor and sesupernatant/well (6-well plate) in the presence of 10 fig/ml polybrene for nescence marker. IGF2 P2, P3, and P4 represent multiple promoters for 6 h. Cells were harvested for RNA and protein 48 h postinfection. Test IGF2 expression. P1 expression was not detected in these cells. WT-1 infections using lentivirus-GFP showed an infection efficiency of 30-negatively regulates IGF2 expression and is expressed minimally at 40% for senescent epithelial cell lines. Experimental results were re-senescence. B, loss of IGF2 imprinting is shown in epithelial cells with produced in two independent cultures, passage to senescence in vitro. The determination of allelic imprinting was performed by reverse transcriptase-PCR of an ApaI polymorphism RESULTS on exon 9. Restriction digest of PCR products was then performed. Uncut (292 bp) and restricted (218 bp) bands represent the two alleles. Senescence and IGF2 Expression in Human Epithelial and Serially passaged human prostate epithelial or urothelial cells (three Urothelial Cell Cultures-HPECs were cultured on collagenindividual cultures) were harvested at the passage 1 proliferating (P) coated plates and a low serum medium to exclude fibroblasts stage and at the early senescence (ES) or terminal senescence (S) stage. (26). Growth of the epithelial cells is brisk through 10-15
Early senescent cells are arrested and contain few proliferating cells (<10%); however, they do not demonstrate the complete senescent population doublings, typically 4-6 passages, at which point morphology (8). With passage to senescence, the imprinted allele was the subconfluent cells undergo growth arrest and adopt a se-re-expressed in all three cultures in vitro. #1, #2, and #3 represent nescent phenotype (32). The epithelial senescent phenotype is multiple independent cultures. C, H19 imprinting is maintained with characterized by morphological changes consisting of an ensenescence. cDNAs were amplified and restricted with RsaI to identify larged, flattened cytoplasm and nucleus and by positive senesexpression from individual alleles (544 and 406 bp, respectively).
cence-associated A-galactosidase staining. Increased expression of p16 RNA (13-fold) and protein, a cyclin-dependent the expression of IGF2 as human prostate epithelial cells were kinase inhibitor, confirm the senescent phenotype (26).
passaged from proliferation to senescence. To confirm these Roughly 70% of the cells develop this phenotype when har-findings, we harvested RNA from multiple sequential passages vested at terminal senescence. Human urothelial cells demonof human prostate epithelial or urothelial cells and performed strate similar growth patterns.
QPCR using IGF2-specific primers (Fig. 1A ). An average inWe had noted previously (8) on cDNA array an increase in crease of 10-fold (-+3.8-fold) in IGF2 was seen with the devel-A. 
#1
#2 #3
pression is seen in senescent cells (S) .
when compared with proliferating cultures (P). #1, #2, and #3 represent multi-P S P S P S ple independent cultures. 3-Actin was applied as a loading control.
CTCF
.
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Acti n opment of senescence. IGF2 expression is driven by multiple with a common regulatory mechanism proposed in mouse modpromoters P1-P4, and as cells were passaged to senescence, the els (41). relative expression from the IGF2 P3 and P4 promoters in-CTCF Binding Decreases at Senescence-The loss of binding creased (9-and 8-fold, respectively). The P2 promoter demonof the insulator protein CTCF in the intergenic IGF2-H19 strated decreased expression (7-fold) but contributed only rel-region has been demonstrated to be important in regulating atively small amounts (15%) to the overall IGF2 expression in biallelic IGF2 expression in mice (12, 43). We assessed the senescent cells. P1 was not expressed. The P3 and P4 promotbinding of CTCF in the H19 ICR region using chromatin imers contain several Wilms' tumor gene 1 (WT-1) binding sites munoprecipitation in populations of senescent and proliferatthat negatively regulate IGF2 expression (39, 40) . Consistent ing cells. The relative levels of CTCF binding at this site were with a putative role for WT-1, we found an 8-fold down-regu-2-fold lower in senescent cultures compared with proliferating lation of WT-1 RNA at senescence. Thus, the overall IGF2 cultures ( Fig. 2A) . Overall, CTCF expression levels were anaexpression increased at senescence, and this was mediated by lyzed in proliferating and senescent cells using QPCR, which an increase in expression from the P3 and P4 promoters. demonstrated a 2-fold (+0.57-fold) decrease in expression. Alterations in IGF2 Imprinting with Senescence-The IGF2 Western analysis confirmed a multifold loss of CTCF protein gene is imprinted, demonstrating expression solely from the expression in senescent cells (Fig. 2B) . Therefore, diminished paternal allele in most adult tissues (1) . RNA obtained from expression of CTCF and decreased binding to the ICR region three separate epithelial cultures was subjected to an imprintwere observed in senescent cultures demonstrating biallelic ing analysis based on an ApaI polymorphism found in exon 9 of IGF2 expression. the IGF2 gene (29). In prostate epithelial cultures, we found Methylation Analysis of the H19 ICR and Other Regions in minimal expression (<5%) of the maternal IGF2 allele in pro-Proliferating and Senescent Human Cells-A detailed methylliferating cultures (Fig. 1B, bands labeled P) . As epithelial cells ation analysis was performed on multiple CpG islands in the were passaged, a relaxation of IGF2 imprinting occurred. Par-IGF2-H19 region as cells were passaged to senescence (Fig.  tial re-expression of the silenced allele was evident in early 3A). The H19 ICR (Fig. 3, A MR3 ) harbors an imprinting mark senescence (Fig. 1, label ES) , a period at which cell growth is (13, 22) and binds CTCF, and the loss of differential methylaminimal, and the senescent morphology is found less fretion correlates with LOI in Wilms' tumors (19) and colon canquently (32). A complete loss of imprinting developed subsecers (20). DNA was harvested from proliferating and senescent quently in terminally arrested, fully senescent cultures.
cells and then treated with sodium bisulfite in a reaction that Data obtained from human tumors and during experimental converts unmethylated cytosines to uridine (then thymidine), manipulation of the mouse genome indicate that the regulation but methylated cytosines remain unaltered. After PCR, indiof IGF2 and its adjacent 3' imprinted gene, H19, are linked (41, vidual alleles were cloned and sequenced. In Fig. 3B , one allele, 42). In three epithelial cultures that were informative for H19 as expected, was methylated completely at more than 25 CpG (one was also informative for IGF2 imprinting), we detected no sites. As three independent epithelial and urothelial cell culchange in the monoallelic status of H19 with the passage to tures were passaged to senescence, no methylation changes senescence (Fig. 1C) cAMP-response element-binding protein binding sites and a methylated sites (<30% of total) than the remaining alleles forkhead (hepatocyte nuclear factor-3/forkhead homolog 1) site.
(>70%), indicating that allele-specific methylation exists in These sites contained partial methylation in proliferating cells. this region (data not shown). Analysis of the methylation status Complete methylation at these sites was also found in epitheof individual alleles demonstrated a reproducible 23 ± 5% lial cultures enriched for senescent cells, as seen by sorting increase in methylation at senescence, occurring primarily based on increased forward scatter (data not shown). Thus, across an Hpall site on the less methylated allele. Analysis of increased methylation did not occur within the CTCF binding methylation demonstrated no significant changes in either site or widely across the H19 ICR on the unmethylated allele; MR4, a region containing allele-specific methylation patterns, however, a focal increase was seen in a downstream region.
or MR1, a region showing no allele-specific methylation. We also analyzed several other CpG islands that have dem-
Treatment of Epithelial Cells with Methylation Inhibitors onstrated (34-37) allele-specific methylation patterns in the
Results in Senescence and Biallelic IGF2 Expression-Hypomouse and are putative ICRs (Fig. 3A) . At MR2, located within methylation has been documented in aging cells in vitro and IGF2 exon 9, we found that 50% of the alleles contained fewer in vivo (44, 45). To investigate the role of accelerated methyl- ation loss, we exposed epithelial cultures to D5-AzaC, a com-morphological changes were noted in the transfected cells. pound that binds and inhibits multiple DNA methyltrans-Western blot demonstrated a decrease of greater than 50% in ferases. Informative epithelial cultures were stained initially CTCF protein expression in transfected cancer cell lines ( Fig.  with CFSE (46) , an inert lipophilic fluorescent compound that 5A). This down-regulation was less marked in proliferating incorporates into the plasma membrane and is divided evenly HPECs (20-40%). Quantitative PCR demonstrated -40-70% between daughter cells after each cell division. The resultant silencing of CTCF RNA expression in siRNA-transfected culintensity is proportional to the number of cell divisions a cultures when compared with controls (data not shown). ture undergoes. For 3 days, epithelial cells were treated with 10 RNA analysis demonstrated a consistent increase in IGF2 j.M D5-AzaC or vehicle alone and then released for 5 days RNA expression in cultures transfected with siRNA (Fig. 5B ). followed by sorting for high CFSE intensity (i.e. cells that have Imprinting was unable to be assessed in the HPECs because of divided rarely) or low intensity (i.e. cells that have divided a lack of the ApaI polymorphism; however, for both PPC-1 and frequently) (Fig. 4A) . The percentage of cells in the low inten-PC3, an increased expression of the silenced and imprinted sity population was minimal in the treated group (1.8%) com-IGF2 allele was demonstrated after siRNA transfection (Fig.  pared with control group (29%) , demonstrating the ability of 5C). These data showed that down-regulating CTCF expression the drug to induce cell growth arrest, results in an increased IGF2 expression and a relaxation of the In treated cultures, a complete relaxation of imprinting ocimprinted IGF2 allele. curred in the high intensity (few divisions) group (Fig. 4B) .
Induction of CTCF Expression in Senescent HPECs Results
This growth-arrested subset up-regulated markers of senesin IGF2 Expression
Increases-Lentiviruses were utilized to cence, including p16, p21, and IGF2 as assessed by QPCR (Fig. express CTCF in infrequently dividing senescent epithelial  4C) . We found that a 3-fold (-0.6-fold) decrease in CTCF excells. We verified the infection efficiency by infecting parallel pression occurred reproducibly in treated cultures in the high cultures with an equivalent titer (see "Materials and Methods") intensity group (Fig. 4C) . When controlling for cell proliferaof virus expressing GFP. At the titers used, the lentiviruses tion, these studies demonstrated that inhibiting methylation transduced -40% of HPECs in senescent cultures. Longer inleads to an accelerated loss of IGF2 imprinting and senescence.
fection periods led to cell death (data not shown 
CTCF IGF2
ment, in cancer, and potentially in other biologic processes (33). a loss of imprinting in colon and prostate tissues occurs in older In the present study, we demonstrate that IGF2 also undergoes patients (3, 2), alterations in imprinting may be an important a loss of imprinting with the development of replicative senesmechanism of gene regulation in aging epithelial cells. A seccence in human prostate epithelial and urothelial cells. Senesond finding is that the loss of imprinting of IGF2 at senescence cence is an in vitro model of aging that mimics mechanistically is associated with a decrease in CTCF binding, an enhancer several aspects of in vivo aging (4, 7, 8). Given the finding that insulator, within the H19 ICR. This is consistent with mouse models and indicates a primary role for CTCF in the IGF2 ing. Alterations in the expression of CTCF would help explain imprinting control pathway in genetically intact human cells, a number of diverse findings in human tissues, notably the Third, we demonstrate that this decrease in CTCF binding is presence of IGF2 LOI in colon tumors containing hypomethymediated by a decrease in CTCF expression, rather than DNA lation of both alleles (24). However, recent data in human hypermethylation. The forced loss of CTCF expression leads to osteosarcomas suggest that other mechanisms exist that may an increase in IGF2 expression and loss of imprinting. Con-bypass the CTCF boundary (51). The proposed down-regulation versely, we find that the increased expression of CTCF in of CTCF represents a novel mechanism for altering the imsenescent cells decreases IGF2 expression. CTCF down-regu-printing of IGF2, and the current model is the first to identify lation is a novel mechanism that may help explain the lack of this as a mechanism in human cells. In addition, the loss of consistent correlation between methylation of the H19 ICR and CTCF expression, which plays a vital role in survival and imprinting found in human tumor tissues (20, 24) . proliferation (43), may represent an important pathway in the The finding that changes in imprinting occur with senes-maintenance, and possibly inception, of senescence. cence has not been reported previously. Senescence is a termiOur results indicate that IGF2 LOI in genetically intact nal phenotype that is important as a tumor suppressor in human cells occurs in the absence of alterations in methylation limiting the growth of cells but may also function in an "antag-at the H19 ICR. Hypermethylation of this region in the mouse onistically pleotropic" manner to overexpress proteins, such as leads to biallelic IGF2 expression, and methylation has been IGF2 or proteases, that may be detrimental to aging tissues (4). considered to be the primary event in the regulation of IGF2 The chronic endogenous/exogenous exposure of cells to higher imprinting (1) . Our analysis focused on methylation changes levels of IGF2 generates multiple tumor types in mice (25); surrounding the sixth CTCF binding site, which contains althus, strict mechanisms are needed to regulate the paracrine lele-specific differential methylation in the human, and a minor and autocrine mitogenic activity of IGF2 (48). In our in vitro gain of methylation at this site has correlated with IGF2 LOI in model of cellular aging, biallelic expression was linked to an colon, bladder, and Wilms' tumors (19, 20, 22) . Alterations in increase in IGF2 expression. At senescence, the reactivated CTCF binding would explain the LOI at senescence in the maternal allele demonstrated expression levels equivalent to absence of hypermethylation of the unmethylated allele. We those of the paternal allele ( Fig. 1 ), yet total concentrations of did find a reproducible increase in methylation at several par-IGF2 increased 10-fold. Clearly, other transcriptional factors or tially methylated CpG sites downstream from the CTCF bindthe loss of repressors contributed to this amplified response. ing site that spans two cAMP-response element-binding proOne candidate down-regulated at senescence in HPECs that tein sites and a forkhead (hepatocyte nuclear factor-3/forkhead may amplify P3 and P4 promoter expression consists of several homolog 1) site. This change may reflect senescence-associated well described WT-1 binding sites that negatively regulate de novo hypermethylation, propagating potentially from the IGF2 expression (39, 40) . These data indicate that imprinting edges of the CpG island (52), an age-related phenomenon seen plays a primary role in regulating IGF2 expression in human at selected CpG islands (e.g. estrogen receptor) (53). Notably, cells and that the loss of imprinting results in a permissive these sites were methylated partially in fully imprinted prolifenvironment with the subsequent multifold increase in IGF2 erating cells, suggesting they do not have a major regulatory expression.
role in the imprint of IGF2. This human system presents a unique opportunity to examWe do not discount completely a role for methylation alterine imprinting and its regulation in genetically intact cells ations in the control of imprinting in human cells undergoing undergoing a programmed and sequential cellular process. senescence. Indeed, our data demonstrate that exposure of This complements and has advantages over single point anal-HPECs to the DNA methyltransferase inhibitor D5-AzaC indiyses of heterogeneous fetal tissues and tumors, which have cate an important role for methylation loss. However, we did provided often conflicting and contradictory data (20, 24). Pros-not document alterations in methylation at the H19 ICR retate epithelial cells represent a relatively homogenous group of gion. Global losses of methylcytosines are associated with aging cells that, once established in culture, have characteristics of a both in vitro and in vivo in humans and have been postulated basal, stem cell phenotype (26, 49) . With passage to senescence, to represent a mitotic clock signaling senescence (10, 44, 45 ). In we demonstrate that IGF2 LOI is associated with the mainte-the aging human prostate, the overall methylcytosine content nance of H19 imprinting consistent with a common regulatory of normal prostate tissues from younger men (mean age 33 mechanism for these two genes. An inverse relationship in years) is significantly higher than that in benign prostatic expression is also noted, with H19 RNA decreasing signifi-hyperplasia and cancer tissues from older men (mean age 76 cantly at senescence. This is consistent with a transcriptional years) (54). We did find that, in HPECs treated with D5-AzaC, model involving access to a common set of enhancers shared CTCF expression was reproducibly down-regulated in cells conbetween IGF2 and H19. One proposed mechanism for this taining IGF2 LOI. The effect of inhibiting methyltransferases reciprocal imprinting is binding of the enhancer-blocker pro-appears to be indirect, by modulating the transcription of tein CTCF to the H19 ICR, located between IGF2 and H19 (50). CTCF or other genes that may modify imprinting. On the unmethylated chromosome, CTCF acts as a transcripThe present study demonstrates for the first time that detional insulator and blocks activation of the IGF2 promoters by velopment of the senescent phenotype, an in vitro model of distal enhancer elements. As cells progress to senescence and aging, is characterized by the up-regulation and biallelic exre-expression of the silenced maternal allele occurs, we find pression of IGF2 in normal epithelial cells. This study examthat a 2-fold decrease in the binding of CTCF to this region ines the regulation of IGF2 imprinting in a genetically intact, supports CTCF in human imprinting control.
homogenous cell population during a programmed process. The We demonstrate in immortalized human prostate cancer loss of CTCF expression as a mechanism in cells for regulating cells and HPECs that the down-regulation of CTCF leads to an IGF2 imprinting is novel. Our data suggest a model in which a increase in IGF2. Furthermore, in cancer cells, a relaxation of loss of CTCF binding mediates IGF2 LOI; however, the majorimprinting was found. The HPECs utilized in this experiment ity of IGF2 expression increases occurs because of altered tranwere not informative for the ApaI polymorphism. This suggests scriptional binding. In human and rat prostate tissues, IGF2 that in cancer cells and possibly in normal human epithelial levels increase with aging (47, 55). Based on these data, we cells CTCF plays a critical role in IGF2 expression and imprint-speculate that alterations in imprinting may occur during cel-The Pennington Scientific Symposium on Mechanisms CR research in humans. During the round-table discusand Retardation of Aging was held in Baton Rouge, sions, speakers and guests identified a few noteworthy Louisiana, USA from May 4-6, 2003. The aim of this highlights of the presentations to be further emphasized symposium was to gather leaders in the field of aging to in the present report. More specifically, this report will discuss the latest theories and mechanisms of aging as focus on three major hypotheses of aging presented well as the life prolonging effects of calorie restriction during Session 1; hormonal regulation, DNA methylation (CR). The overall program and list of speakers is and nutrient sensing. From Session 2, we report on presented in Appendix A. To encourage lively discussion, potential biomarkers of aging and the latest results from speakers were invited to bring one guest who had either the ongoing CR trials in non-human primates. similar or opposing views to their own. During the first session, several views of aging with respect to the endocrine system, brain function, cardiovascular function, Session 1: Theories of Aging in Tissues and Organs immune system and susceptibility to cancer were presented. The second session focused on mechanisms Aging may be defined as the gradual and progressive of life extension by CR induced alterations in neurodeterioration in function of an organism. However, it is endocrine pathways, gene expression, mitochondrial unclear exactly why organisms age. Steven Austad began energy metabolism and oxidative stress. The program the symposium with an insightful lecture about the many ended with a lengthy round-table discussion to facilitate existing theories of aging. He focused on the major causal communication on how these studies could translate into theories including: (1) mechanistic approaches must be combined to most clearly The decline in the GH axis that is observed with aging address these questions in the future.
and body composition and metabolic changes that may be associated with this process are termed the somatopause. An A. Hormone Profile and Longevity increase in central adiposity, a decline in lean body mass, strength, bone mass, slow wave sleep and renal blood flow The influence of the endocrine system on aging may all be associated with somatopause, since many of processes and life span has garnered major attention by these resemble those changes found in adult GH deficiency. biogerontologists over the past few years. This is because Replacement studies in growth hormone deficient adults many hormones display a gradual, progressive decline show substantial reversal of these symptoms following with aging, sometimes beginning years before the posttreatment with GH. While GH supplementation in older reproductive stage of life. Examples include testosterone individuals has produced improvements in body compo-(T), dehydroepiandrosterone sulfate (DHEAS), growth sition (lean and fat mass, as well as fat distribution), hormone (GH), and insulin-like growth factor-I (IGF-1).
relatively few changes in function or strength have been It is currently hypothesized that declines in the serum demonstrated (Brill et al., 2002) . In addition, the side effects concentrations of these hormones may lead to decline in of GH treatment are many and include carpal tunnel physiologic function. A new theory, the 'Mitogenicsyndrome, insulin resistance and concern regarding exacerDifferentiaton Theory of Aging', challenging this view bation of tumor growth. A recent clinical trial in older was also presented at this symposium (Bowen and women using growth hormone releasing hormone revealed Atwood, submitted). This theory proposes that the fewer side effects, a 25-30% increases in IGF-I levels, hormones regulating reproduction act in an antagonistic improvement in lean and fat mass as well as fat distribution pleiotrophic manner to control aging via cell cycle (R.S. Schwartz, conference communication). However, signaling, promoting growth and development early in these beneficial effects disappeared following completion life in order to achieve reproduction. However, later in of the hormone treatment. The overall concern is that little is life, in a futile attempt to maintain reproduction, these known about the long-term physiological outcomes of same systems become dysregulated and drive senescence.
hormone administration to older adults. The decline in the levels of hormones in elderly patients Reduced signaling through the GH/IGF-I pathway frequently do not meet the defined criteria for hormone results in life span extension in multiple species including deficiency suggesting that the term supplementation Kenyon et al., 1993; Tatar et al., 2001) . Of the hypogonadal males corrects the reduced muscle and bone mammalian longevity mutants, the Ames and Snell dwarf mass, loss of strength, increased fat mass, decreased libido mice are GH deficient resulting in low to non-detectable and the altered mood and cognitive abilities (Wang et al., levels of plasma IGF-1 [reviewed by (Bartke and Turyn, 2000) . Although this symptom complex is similar to that 2001)]. Another mutant, the growth hormone receptor commonly observed in aging males, few T supplementation/ knockout mice (GHR KO) are also long-lived, but have replacement studies have been conducted in older men, high levels of endogenous GH (Coschigano et al., 2000) . where T levels are more likely to be in the low-normal Bartke and coworkers (Bartke and Turyn, 2001 ) have range. The androgen, DHEAS declines -80% by age 80 focused on insulin signaling in both the Ames dwarf and the and is a well-known biomarker of aging (Roth et al., 2001 a) .
GHR KO mice. In these animals, peripheral insulin and The low levels reached in almost all older individuals have glucose levels are reduced and glucose responses to injected been correlated with cognitive impairment, atherosclerosis insulin are enhanced, suggesting increased insulin sensiand insulin resistance. Clinical trials using supraphysiologic tivity. However, administration of both glucose and insulin replacement doses of DHEA have reported harmful side suggest that these animals may exhibit insulin resistance in effects similar to those observed with anabolic steroid skeletal muscle and have reduced insulin release by the 13-excess. However, trials in older adults using lower cell, but have increased insulin sensitivity of the liver. Thus, replacement doses revealed potentially important benefits suppression of somatotropic signaling, along with secondsuch as increases in bone mineral density, fat-free mass and ary changes in insulin release and actions may lead to improved insulin action (Villareal et al., 2000) . Because the delayed aging and prolonged longevity in laboratory mice. completed studies have all been short term and not well
The mitogenic-differentiation theory of aging puts forth controlled, new studies are currently being conducted to a novel alternative mechanism by which these hormones study the effects of DHEAS replacement in men and women function and may help explain aging in all sexually in longer, double-blind, randomized, placebo-controlled reproductive life forms. This theory suggests a new trials (R.S. Schwartz, conference communication). These definition of aging-any change in an organism over important trials will address the effects of DHEAS on body time. This definition includes not only the changes composition, insulin action and physical function in older associated with the loss of function (i.e. senescence; the individuals.
commonly accepted definition of aging), but also the changes associated with the gain of function (growth and (Bartke et al., 2002; Brown-Borg et al., 1996; Kinney et al., development) . Using this new definition, the rate of aging 2001b). Fertility is also quantitatively reduced in GHR KO would be synonymous with the rate of change. The rate of mice, animals that retain cognitive function in old age when change (aging) is most rapid during the fetal period when compared to normal control mice (Kinney et al., 200 1a) . In organisms develop from a single cell at conception to a sharp contrast, the short-lived, large, GH transgenic mice multi-cellular organism at birth. Therefore, fetal aging is enter puberty significantly earlier than wild type animals, determined by the rate of mitogenesis and differentiation, and exhibit several indices of premature aging including This theory suggests that mitogenesis and differentiation signs of early cognitive impairment [reviewed by (Bartke also are responsible for aging throughout life. Since lifeet al., 2002) ]. Therefore, maintenance of several aspects of extending modalities consistently affect reproduction, and brain functioning with age and the relationship to the reproductive hormones are known to regulate mitogenesis gonadotropins and growth and development are deserving and differentiation, it is proposed that aging is primarily of future research efforts in the quest to delay aging regulated by hormones controlling reproduction. By having in humans. hormones that are sensitive to environmental conditions regulate both reproduction and aging, an organism is able to B. Age-related Alterations in Genomic Imprinting: DNA modulate its fertility and its rate of aging based on Methylation environmental conditions. Therefore, under hostile conditions (i.e. CR, cold, stress), fertility is preserved and Epigenetic alterations have been postulated to modulate longevity extended awaiting a friendlier reproductive the aging processes and represent susceptibility factors that environment.
may underlie the increase in cancer rates in the elderly. In In mammals, reproduction is controlled by the hypothe case of prostate cancer, the most commonly diagnosed thalamic--pituitary-gonadal (HPG) axis. The centrally solid tumor in US males, deaths are expected to increase produced hormones may represent the mitogenic factor(s) with the increasing geriatric population. The molecular while the peripherally produced hormones may represent events that underlie this disease are not well understood, the differentiation factors. Longevity inducing intervenhowever, several observations provide insight into its tions, including CR, decrease fertility by suppressing development. It is a disease of aging with the latent form centrally produced HPG axis hormones thereby affecting of the disease found in -75% of men by age 80 (Haas and signaling through the IGF-I pathway, which may regulate Sakr, 1997) . Another striking observation is that the longevity in some animal models. This is exemplified by majority of prostate cancers (over 75%) arise in the genetic alterations in C. elegans where homologues of peripheral region of the prostate. Even more remarkable is the HPG axis pathways, as well as the daf-2 and daf-9 the observation that in radical prostatectomy specimens pathways, all converge on daf-16, the homologue of human removed for cancer, typically four independent foci of Forkhead, that is known to be important in the regulation of cancer can be found (Epstein et al., 1994) . This suggests that cell cycle events. Therefore, the dysregulation of cell cycle in the peripheral prostate, a field effect has occurred that has events caused by changes in reproductive hormones is a lead to cancer promotion in multiple cells. common mechanism, which could drive degenerative One candidate underlying both this field defect and changes during senescence. The most obvious of these is regional predilection of prostate cancer is the observation cancer, however, Alzheimer's disease may be also due to an that a loss of Insulin-like Growth Factor-II (IGF-I1) aberrant re-entry of neurons into the cell cycle (Raina et al., imprinting occurs in histologically normal peripheral 2000; Yang et al., 2001) . Interestingly, it has been shown prostate tissues (Jarrard et al., 1995) . The IGF-li gene is that individuals with Alzheimer's disease have elevated stringently imprinted in adult tissues, and biallelic serum concentrations of gonadotropins (Bowen et al., 2000) expression, associated with IGF-II upregulation, has been and elevated neuronal luteinizing hormone concentrations implicated in cancer development . Given corresponding to those regions of the brain most damaged this age-dependency of prostate cancer, and the fact that an by the disease (Bowen et al., 2002) . Luteinizing hormone imprint control mechanism (i.e. DNA methylation) is also modulates the processing of the amyloid-P3 precursor altered with aging, loss of IGF-lI imprinting may be an protein and the generation of AP, the major component of acquired molecular event that can be reversed or modulated. amyloid plaques that deposit in the Alzheimer's brain (C.S.
Genomic imprinting is an epigenetic modification in the Atwood, conference communication).
gamete or zygote that results in the silencing of a specific One intriguing commonality among the endocrine work parental allele in the offspring. Thus, in contrast to most presented is the relationship between the reproductive genes, imprinted genes (roughly 40 are known) express only hormones, growth hormones (GH, IGF-1) and aging. The from one allele (Morison et al., 2001) . IGF-Il is located at evidence indicates that the mutant mice that live longest llp15 and exhibits monoallelic expression from the exhibit the greatest degree of gonadal suppression and paternal allele in most adult tissues (Pfeifer, 2000) . interestingly, do not exhibit the age-related decline in Exceptions include specific regions of the brain and possibly cognitive function normally observed in wild type mice the liver. IGF-H is an embryonic mitogen with a clear role as a paracrine and autocrine regulator of cell proliferation in model, a threshold level for IGF-II imprinting may be the human prostate (Cohen et al., 1994 IGF-II occurs with the passage of human prostate epithelial when compared to normal tissues, and in more pathologicells to senescence in vitro (unpublished data). This is cally advanced stages of the disease (Fichera et al., 2000;  associated with a multifold increase in IGF-1I expression Ho and Baxter, 1997; Tennant et al., 1996) . Notably, longlevels. In the aging rat prostate, an eight-fold increase in term, chronic endogenous or exogenous exposure appears to IGF-H protein expression has been noted (Slater et al., be especially important in the generation of tumors.
2000) but, to date levels in the aging human prostate have Transgenic mice engineered to re-express IGF-Il as adults not been reported. Given data demonstrating a role for develop diverse carcinomas only after a long latency period increased IGF-II levels in the promotion of cancer, (Rogler et al., 1994) .
including prostate cancer, it is postulated that the relaxation Loss of imprinting, or a re-expression of the silenced in IGF-H imprinting may play a role as a switch to initiate allele, has been implicated in the pathogenesis of cancer the development of a field of susceptibility that is ultimately (Rainier et al., 1993) . Loss of imprinting of IGF-IH was first manifest by the multifocal tumor generation seen in prostate demonstrated in Wilms tumors (Ranier et al., 1994) , an cancer specimens. embryonic tumor of childhood, but the same abnormality A mechanism for retarding these changes in methylation, has also been noted in colon (Cui et al., 1998) and prostate and potentially imprinting is diet. In animals, a number of cancers (Jarrard et al., 1995) . A number of these studies factors implicated in aging have been shown to accelerate demonstrate that a relaxation of IGF-II imprinting correlates the loss of DNA methylation. These include free radical with higher levels of IGF-II expression.
accumulation (Weitzman et al., 1994) (Reik et al., 2000) .
and Andrews, 1993) . It has also been proposed that caloric ICRs provide gametic marks that establish parent of origin restriction retards aging by restricting methylation dependent expression domains. The ICR between IGF-II metabolism, thus slowing the rate of loss of methylation and H19 expresses paternal IGF-II in the methylated state, (Cooney, 1993) . Therefore, should the proposed hypothesis yet blocks expression in the maternal allele when unmethybe validated, a number of options for reversing lated. The repression of the maternal allele involves binding these methylation and imprinting changes are available of the chromatin insulator factor CTCF, which binds only to for testing. unmethylated DNA in this ICR and blocks the access of downstream enhancer proteins to the promoter. It is not C. Master Regulators of Aging clear whether the loss of CTCF binding leads to de novo methylation or the converse, however, DNA methylation
The 'metabolic syndrome of insulin resistance' repcertainly plays an important role. Disruption of resents a constellation of defects that are important risk DNA methylation, using a methyltransferase-knockout factors for age-related diseases (Hansen, 1999; Reaven, mouse (embryonic lethal) , leads to a loss of the normal 1988). This syndrome is linked to excess nutrients since it is imprint status of IGF-II, H19 and p57 (Li et al., 1993) , most commonly associated with obesity, particularly and the treatment of non-immortalized cells with methylabdominal obesity, and is a risk factor for all-cause transferase inhibitors results in biallelic IGF-II expression mortality (Calle et al., 1999) . It is also commonly associated (Hu et al., 1996) .
with the development of type 2 diabetes mellitus, the It has been well documented that with aging, global incidence of which increases dramatically with aging hypomethylation occurs associated with regional hyper- (Harris et al., 1998) . Furthermore, this syndrome increases methylation (Issa, 1999) . It has been proposed that DNA the risk for thrombosis and coronary artery occlusion. Other methylation changes seen in aging may contribute to altered manifestations of the metabolic syndrome, such as hyperimprinting of the IGF-H gene. This process is further tension and dyslipidemia, contribute to the marked increase modulated by environmental or somatic causes that may in risk of developing atherosclerosis. Of interest, this accelerate the relaxation of IGF-II allelic imprinting. In this syndrome has been characterized as a pro-inflammatory state with increased plasma levels of various adipose approximately 1-3% of the incoming glucose that is associated cytokines and acute phase reactants. The latter converted to fructose-6-phosphate (F-6-P) enters HBP (see may in turn be implicated in the etiology of several age- Figure) . This occurs by the action of the rate limiting related diseases. Finally, insulin resistance and central enzyme glutamine, F-6-P amidotranseferase (GFAT), and obesity might also be a risk factor for a variety of cancers, results in the 0-glycosylation of intracellular proteins by NThus, the metabolic syndrome is likely to play a central acetylglucosamine. As an example, this glycosylation role in biological processes that link it to shorter life span in pathway activates the transcription factor SPI, which is humans. It is generally postulated that insulin resistance involved in the nutrient-mediated modulation of the plays a causative role in the various components of the expression of numerous proteins. With excess nutrient metabolic syndrome (linear model). However, recent intake, HBP flux may increase several folds, making HBP studies have suggested that chronic excess of nutrients an ideal 'sensing' mechanism for nutrient availability. leading to the activation of nutrient-sensing pathway/s may play a direct role in the pathogenesis of both insulin resistance and various other components of the metabolic T Glucose syndrome (parallel model). It has been suggested that these!' direct effects of nutrients are likely to be partly mediated via enhanced glycosylation and altered gene regulation of key e; =. ==_ lucose6"P proteins.
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Undecesier norm lablcircmtafnctrens, the deetrousteffect of theN Rossetti et al., 1995) , acute Importantly, decreased caloric intake has been associated induction of the HBP increases the gene expression of a with increased life span and a decreased incidence of agevariety of adipose tissue-derived peptides and cytokines related illness in many species (Barzilai and Gupta, 1999) . (Gabriely et al., 2001 (Gabriely et al., , 2002 . During aging, the chronic Indeed, diseases associated with obesity in humans are increase in the levels of plasma glucose and free-fatty mirrored by ad libitum (AL) feeding in other species. For acids leads to increased intracellular concentrations of example, AL fed models are insulin resistant and have F-6-P. This in turn results in further increased activity of shorter life spans than CR models. Since fat tissue has the HBP. The HBP has been recently implicated in some previously been viewed as an inert depot for nutrient of the vascular complications of diabetes, which have storage, prevailing scientific opinion has supported a striking similarities to those seen with aging (Du et al., dominant role for decreased nutrient intake per se in the 2000). Indeed, advanced glycosylation end products protective effects of CR. However, adipose tissue is an increase with aging, suggesting that this pathway is active endocrine organ whose secretory products include already up-regulated and may be more sensitive to nutrient hormones, cytokines, and complement factors that can be flux. Because a chronic increase in nutrients can directly measured in physiological levels in plasma. These obserincrease carbon flux through the HBP, it may have a vations have alerted investigators to the possibility that potential role in the metabolic syndrome of aging and on increased fat mass, might in turn lead to negative sequelae in the mechanisms mediating the beneficial effects of CR. remote organs. Furthermore, nutrients may directly activate metabolic pathways that have important systemic effects and that may initiate age-associated diseases.
Session 2: Mechanisms of Life Extension Based on ongoing investigations in Dr Barzilai's laboratory, it is hypothesized that the hexosamine biosynEvidence that CR retards aging and extends median and thesis pathway (HBP) is a central nutrient-sensing mechanmaximal life span was first described nearly 70 years ago ism (see Figure) . Activation of HBP induces insulin (McCay et al., 1935) . Since then, similar observations have resistance and regulates the secretion of several adiposebeen made in a variety of species including rats, mice, fish, derived peptides (McClain and Crook, 1996;  flies, worms and yeast (Barrows and Kokkonen, 1982; Wang et al., 1998) . While most intracellular glucose Weindruch and Walford, 1988) . From these studies is directed toward glycogen synthesis or glycolysis, numerous potential biomarkers of aging have been found.
Based on the biomarkers obtained from other species, the Barger et al. [submitted] ) which include Ames and Snell results obtained from the CR trials in non-human primates dwarf mice, 'little' mice, IGF-1 receptor mutants and are consistent with the theory that CR also is likely to p66 hc-/-mice suggest the importance of investigating increase life span in longer-lived species (Bodkin et al., putative biomarkers of aging in these models. This takes on 1995; Kemnitz et al., 1993; Lane et al., 1998) .
additional importance as it can be argued that, for most of these models, the effects on longevity are not too impressive A. Biomarkers of Aging as compared to that exerted by CR.
A new area of inquiry is the attempt to develop drug or The term 'biomarkers of aging' implies parameters, nutrient interventions (mimetic) that may mimic the which allow one to reliably estimate biological or actions of CR (Lane et al., 2002; Weindruch et al., 'functional' age, as opposed to chronological age, for 2001) . A challenge in that regard is the aforementioned any subject. A good biomarker or set of biomarkers might significant shortcomings associated with the current 'gold also be expected to offer predictive information on the standard' of life extension for screening interventions that future longevity of an individual. There is no clear may retard aging. Besides the long time frame required, distinction between physiological changes that occur with this life extension assay provides imprecise data on the age and what may be labeled 'biomarkers of aging.' It is rate of aging in individual organ systems (e.g. did the obviously not sufficient to follow a parameter that candidate mimetic retard aging in the heart, the brain?). undergoes a change with age and treat that as a Importantly, advances in genomics provide exciting new biomarker.
opportunities and have created the new field of 'nutrige-CR slows the rate of change of numerous parameters that nomics' which can be applied to this problem. It has been are normally observed with aging. These include parameters argued that the use of microarrays to generate gene that are not clearly disease related, such as collagen in rats expression profiles (which consist of hundreds of markers (Everitt, 1971) To address the relevance of CR to humans, nonstandard' for testing the efficacy of an intervention to retard human primate studies were initiated at the National the aging process. However, there are serious shortcomings Institute on Aging (NIA) in 1987 ) with this assay including its cost, the time required and its and at the University of Wisconsin (UW) in 1989 inability to provide direct information on the biological age (Kemnitz et al., 1993) . The studies were intended to of individual tissues, especially since different tissues age at provide the experimental control that would be difficult different rates. to achieve in human studies, while expanding knowledge In longer-lived species, such as humans, longevity about the biological effects of CR beyond the rodent determination is not practical, and methods to determine model. The total number of monkeys involved in the over a relatively short space of time whether the rate of NIA longitudinal study is about 120 with roughly equal aging is being influenced are required. The National numbers of control and CR monkeys. The UW study Institute on Aging has long supported development of began with only mature adult male rhesus monkeys and biomarker research (Baker and Sprott, 1988; Reff and later (1994) added additional mature adult male and Schneider, 1982). Desirable features of good biomarkers female monkeys for a total of 64 monkeys roughly include: (1) it be measurable without harming the subject, divided among control and CR groups. Knowledge about (2) it be highly reproducible and reflect physiologic CR in non-human primates will therefore be exclusively ('functional') age, (3) it shows significant age-related derived from studies of rhesus monkeys that have a usual changes within a relatively brief time period (in relation median life span of around 25 years and a maximum life to the organism's life span), and (4) the clinical functions span of 40 years. should be crucial to the health of the species (Reff and Both studies targeted a 30% reduction in caloric intake. Schneider, 1982) .
For the UW study this reduction was made from baseline The recent series of publications describing increased measurements of intake for individual monkeys. Because longevity in several types of mutant mice (reviewed by the NIA study incorporated a wide age range including the development stage, caloric intake for the CR monkeys attenuated in older monkeys on CR (Mascarucci et al., was based on a reduction from age-and weight-matched 2001). The UW study has also utilized gene array control monkeys. Food allotments for the control group technology to assess whether CR alters age-related were derived from tables developed by the National changes in the pattern of gene expression (Kayo et al., Research Council (NRC) regarding recommended levels 2001). Finally, new techniques continue to emerge from of caloric intake for rhesus monkeys of specific age and these studies. For example, the NIA study has developed body weights. Details on the diet (standardized natural an in vitro assay to assess possible mechanisms of CR. ingredient diet for NIA and purified diet for UW) and study Specifically, cells grown in serum from CR monkeys design can be found elsewhere ; Kemnitz exhibit enhanced survival and stress responses when et Lane et al., 1999) . CR regimens in both studies subjected to various challenges (de Cabo et al., 2003) . have proven to be generally safe in their implementation While findings emerging from these studies appear with virtually no untoward health effects reported.
encouraging regarding the potential beneficial effects of CR in both studies has produced the expected CR on aging processes in monkeys, it remains premature alterations in body composition, including reduced body to reach a final conclusion. Conclusive evidence that CR weight and fat mass (Blanc et al., 2003; retards the rate of aging in these studies will require three 1995). For juvenile monkeys in the NIA study, lean mass vital elements of proof as follows: (1) reduction in and height were also reduced in CR monkeys, and their mortality rate; (2) reduced incidence of age-related development, as measured as delays in puberty and bone disease and pathology; and (3) enhanced function at growth, was retarded (Lane et al., 1995b) . In general, older ages. Regarding mortality and disease incidence, physiological effects of CR have paralleled most of those trends in the studies appear to support the beneficial reported in rodent models . As effects of CR; however, these trends are presently not examples, in CR monkeys body temperature is reduced statistically significant. Regarding function, data have (Lane et al., 1996) and plasma glucose and insulin levels demonstrated age-related declines in visual accommoare lower (Lane et al., 1995a) . Metabolic rate is also dation and auditory acuity in the NIA study, but CR had reduced during the early phases of CR, but generally not attenuated these changes (Torre et al., 2003) . In the equilibrates to control levels as body composition is UW study, some elements of auditory function appeared altered after many months on CR to be enhanced in the CR group (Fowler et al., 2002) . In 1996). UW adult CR monkeys exhibit some reductions in simple learning tasks, no beneficial CR effects have been metabolic rate measured primarily as resting energy noted thus far in the NIA study. Further analyses are expenditure (Blanc et al., 2003) .
ongoing including correlating behavioral function with Both studies have reported that CR monkeys manifest in vivo brain imaging. Age-related declines in the volume lower risk factors for age-related diseases. For example, of the striatum as well as reduced binding potential of monkeys in the NIA study have lower heart rates, systolic dopamine D2 receptors in this brain region have been blood pressure, and serum triglycerides while maintaining documented in the NIA monkeys ). higher levels of specific HDLs that would indicate reduced Similar studies are being planned for the UW study. New risk of heart disease (Lane et al., 1999) . CR monkeys in both studies currently underway for the NIA study including the NIA and UW studies have enhanced glucose tolerance further analyses of reproductive physiology, oral health, and insulin sensitivity (Cefalu et al., 1999; immune function, skeletal structure, and chromosomal 1995a) with few reported cases of diabetes (NIA = 2; aberrations, all of which have emerged from a recently UW = 1).
approved grant program to outside collaborators. CR has also been shown to alter age-related hormonal In summary, both the NIA and UW studies have changes. For example, the usual declines in the adrenal demonstrated the feasibility and potential utility of steroid, dihyroepiandrosterone, and the pituitary hormone, conducting long-term studies of aging in rhesus monkeys melatonin, are attenuated in older CR monkeys in the involving CR as an intervention. Both studies are NIA study Roth et al., 2001b) . The approaching critical stages in their evolution as their UW study has focused on molecular markers of oxidative monkeys approach geriatric ages that will offer many stress and has identified reduced production of protein opportunities for further elucidation of the long-term carbonyls reduced mitrochondrial DNA deletions in effects of CR and possible mechanisms that regulate these muscle biopsies taken from CR monkeys (Zainal et al., effects. 2000) and reduced cytokine responses to xanthine oxidase in monocytes from CR monkeys (Kim et al., 1997) . In the NIA study, despite reports of reduced Summary number of lymphocytes occurring during early stages of CR, the ability of monocytes to deal with an inflammaThe Pennington Symposium on Aging was a successful tory challenge appears to be enhanced. Specifically, the forum for focused discussions on mechanisms of aging and age-related decline in production of interferon-gamma is the impact of CR on these mechanisms. In this report, we presented the current thinking on a few theories of aging as Arlan G. 
